BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33372106)

  • 1. Optimised architecture-based grading system as an independent prognostic factor in resected lung adenocarcinoma.
    Qiu JH; Hu GM; Zhang RZ; Hu M; Li Z; Zhang Y; Wu HF; Fu WJ; Zhang M; Feng YK; Niu L; Ren JL
    J Clin Pathol; 2022 Mar; 75(3):176-184. PubMed ID: 33372106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.
    Moreira AL; Ocampo PSS; Xia Y; Zhong H; Russell PA; Minami Y; Cooper WA; Yoshida A; Bubendorf L; Papotti M; Pelosi G; Lopez-Rios F; Kunitoki K; Ferrari-Light D; Sholl LM; Beasley MB; Borczuk A; Botling J; Brambilla E; Chen G; Chou TY; Chung JH; Dacic S; Jain D; Hirsch FR; Hwang D; Lantuejoul S; Lin D; Longshore JW; Motoi N; Noguchi M; Poleri C; Rekhtman N; Tsao MS; Thunnissen E; Travis WD; Yatabe Y; Roden AC; Daigneault JB; Wistuba II; Kerr KM; Pass H; Nicholson AG; Mino-Kenudson M
    J Thorac Oncol; 2020 Oct; 15(10):1599-1610. PubMed ID: 32562873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade tumor classified by new system is a prognostic predictor in resected lung adenocarcinoma.
    Yoshida C; Yokomise H; Ibuki E; Go T; Haba R; Kadota K
    Gen Thorac Cardiovasc Surg; 2022 May; 70(5):455-462. PubMed ID: 35050467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung.
    Tsai PC; Liu C; Yeh YC; Chen CK; Hsu PK; Chen HS; Huang CS; Hsieh CC; Hsu HS; Huang BS
    Sci Rep; 2021 May; 11(1):9539. PubMed ID: 33953254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.
    Warth A; Muley T; Meister M; Stenzinger A; Thomas M; Schirmacher P; Schnabel PA; Budczies J; Hoffmann H; Weichert W
    J Clin Oncol; 2012 May; 30(13):1438-46. PubMed ID: 22393100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection.
    Jiang MQ; Qian LQ; Shen YJ; Fu YY; Feng W; Ding ZP; Han YC; Fu XL
    Neoplasia; 2024 Apr; 50():100979. PubMed ID: 38387107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal of a revised International Association for the Study of Lung Cancer grading system in pulmonary non-mucinous adenocarcinoma: The importance of the lepidic proportion.
    Park BJ; Woo W; Cha YJ; Shim HS; Yang YH; Moon DH; Kim BJ; Kim HE; Kim DJ; Paik HC; Lee JG; Lee S; Lee CY
    Lung Cancer; 2023 Jan; 175():1-8. PubMed ID: 36436241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
    Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
    Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society grading system has limited prognostic significance in advanced resected pulmonary adenocarcinoma.
    Westaway DD; Toon CW; Farzin M; Sioson L; Watson N; Brady PW; Marshman D; Mathur MM; Gill AJ
    Pathology; 2013 Oct; 45(6):553-8. PubMed ID: 24018816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.
    Duhig EE; Dettrick A; Godbolt DB; Pauli J; van Zwieten A; Hansen AR; Yang IA; Fong KM; Clarke BE; Bowman RV
    J Thorac Oncol; 2015 Apr; 10(4):673-81. PubMed ID: 25514800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma.
    Chen Y; Wu J; You J; Gao M; Lu S; Sun C; Shu Y; Wang X
    Med Phys; 2024 May; ():. PubMed ID: 38781536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
    Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study].
    Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN
    Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the cribriform pattern in invasive adenocarcinoma of the lung.
    Zhang R; Hu G; Qiu J; Wu H; Fu W; Feng Y; Zhang M; Chen C; Sun J; Zhang Y; Ren J
    J Clin Pathol; 2019 Oct; 72(10):682-688. PubMed ID: 31253654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
    Kim M; Chung YS; Kim KA; Shim HS
    Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth pattern-based grading of pulmonary adenocarcinoma-Analysis of 534 cases with comparison between observers and survival analysis.
    Boland JM; Wampfler JA; Yang P; Yi ES
    Lung Cancer; 2017 Jul; 109():14-20. PubMed ID: 28577944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma.
    Warth A; Muley T; Kossakowski C; Stenzinger A; Schirmacher P; Dienemann H; Weichert W
    J Thorac Oncol; 2015 Apr; 10(4):638-44. PubMed ID: 25634008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.